Literature DB >> 12657102

Histopathological analysis of angiogenic factors in renal cell carcinoma.

Hiroki Yagasaki1, Nozomu Kawata, Yukie Takimoto, Norimichi Nemoto.   

Abstract

AIM: The present study was carried out to clarify whether a histopathological analysis of vascular endothelial growth factor (VEGF), transforming growth factor-beta1 (TGF-beta1) and matrix metalloproteinase 2 (MMP-2) can help predict the outcome of renal cell carcinoma (RCC). We examined the expression of VEGF, TGF-beta1 and MMP-2 in a large series of RCC with a long follow-up, based on histopathological factors and survival.
METHODS: Immunostaining for VEGF, TGF-beta1 and MMP-2 was performed on formalin-fixed, paraffin-embedded tissue sections from 84 patients with RCC who underwent nephrectomy at our institution between 1985 to 2000. The microvessel density (MVD) of tumor tissue was measured after it immunohistochemically stained with CD105 (Endoglin) monoclonal antibody.
RESULTS: A significant association was observed in the expression of VEGF and TGF-beta1 regarding the stage (P < 0.01, P < 0.01), nuclear grade (P < 0.01, P < 0.01) and MVD (P < 0.001, P < 0.001), respectively. However, no correlation was found among the results of MMP-2, nuclear grade and MVD. A multivariate analysis demonstrated both the nuclear grade and MVD to be independent prognostic factors.
CONCLUSION: Our results suggested that the expression of both VEGF and/or TGF-beta1 can be useful predictive prognostic factors RCC. In addition, a multivariate analysis demonstrated MVD to be an independent prognostic factor of RCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657102     DOI: 10.1046/j.0919-8172.2003.00608.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  13 in total

Review 1.  Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis.

Authors:  Si-Hang Cheng; Jia-Ming Liu; Qin-Yu Liu; De-Yi Luo; Bang-Hua Liao; Hong Li; Kun-Jie Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.

Authors:  Joanna-W Ho; Ronnie-T Poon; Chris-K Sun; Wei-Cheng Xue; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

3.  Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Niki J Agnantis; Dimitrios Stefanou
Journal:  Virchows Arch       Date:  2006-04-13       Impact factor: 4.064

4.  CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma.

Authors:  Elvir Zvrko; Anton Mikic; Ljiljana Vuckovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

5.  Lack of association of microvessel density with prognosis of renal cell carcinoma: evidence from meta-analysis.

Authors:  Bing Zhang; Hong Ji; Dongliang Yan; Shaoqing Liu; Benkang Shi
Journal:  Tumour Biol       Date:  2013-11-23

6.  Association between microvessel density and histologic grade in renal cell carcinomas.

Authors:  Nikolaos Kavantzas; Helen Paraskevakou; Sofia Tseleni-Balafouta; Kyriaki Aroni; Pauline Athanassiades; George Agrogiannis; Efstratios Patsouris
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

7.  Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion.

Authors:  C-H Chen; C-Y Su; C-Y Chien; C-C Huang; H-C Chuang; F-M Fang; H-Y Huang; C-M Chen; S-J Chiou
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640

8.  Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.

Authors:  Lian-yue Yang; Wei-qun Lu; Geng-wen Huang; Wei Wang
Journal:  BMC Cancer       Date:  2006-05-02       Impact factor: 4.430

9.  Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer.

Authors:  Ester Fonsatti; Michele Maio
Journal:  J Transl Med       Date:  2004-06-11       Impact factor: 5.531

10.  Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma.

Authors:  A Saroufim; Y Messai; M Hasmim; N Rioux; R Iacovelli; G Verhoest; K Bensalah; J-J Patard; L Albiges; B Azzarone; B Escudier; S Chouaib
Journal:  Br J Cancer       Date:  2014-03-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.